从肺体积中排除PTV可能更好地预测肺癌患者调强放疗的放射性肺炎
该研究回顾性分析了2014年1月至2017年10月接受调强放疗的183例连续肺癌患者,比较三种正常肺定义(全肺、排除PTV的肺、排除PGTV的肺)所得的剂量学参数对急性2级及以上放射性肺炎(RP2)的预测准确性。26例(14.2%)发生急性RP2;不同肺定义间剂量学参数差异显著(P<0.001)。排除PTV的肺所得平均肺剂量(MLD)预测性能最佳(AUC=0.647),显著优于排除PGTV的肺所得MLD(AUC=0.609,P=0.006)。
要点
- 183例肺癌IMRT患者中26例(14.2%)发生急性RP2。
- 三种肺定义间剂量学参数差异显著(P<0.001)。
- 排除PTV的肺所得MLD预测RP2的AUC=0.647,优于排除PGTV的肺所得MLD的AUC=0.609(P=0.006)。
核心结论
- 不同正常肺定义所得的剂量学参数对急性RP2发生率的预测存在显著差异。
- 从全肺体积中排除PTV可能更准确且有前景地预测接受IMRT的肺癌患者的急性症状性放射性肺炎。
研究设计与样本
- 回顾性分析2014年1月至2017年10月接受IMRT的183例连续肺癌患者。
- 正常肺分别定义为总双侧肺体积(全肺)、排除PTV(Lung-PTV)或排除PGTV(Lung-PGTV)。
- 从三种定义中提取V5、V20和平均肺剂量(MLD);主要终点为急性2级及以上放射性肺炎(RP2)。
- 采用逻辑回归分析RP2与剂量参数的相关性,用受试者工作特征曲线下面积(AUC)和正常组织并发症概率(NTCP)模型评估预测性能。
主要发现
- 26例患者(14.2%)在IMRT治疗后发生急性RP2。
- 任意两种肺体积定义之间均发现显著的剂量学差异(P<0.001)。
- 为使RP2发生率低于20%,Lung-PTV、Lung-PGTV和全肺方法的MLD截断值分别为12.5 Gy、14.2 Gy和15.0 Gy。
- 在各自MLD截断点,Lung-PTV和Lung-PGTV定义分别检测到54%(13% vs. 20%)和45%(20% vs. 29%)的RP2概率差异。
- Lung-PTV方法所得MLD的RP预测性能最佳(AUC=0.647),显著优于Lung-PGTV方法所得MLD(AUC=0.609,P=0.006)。
关键数值与推荐
- 为使RP2发生率低于20%,Lung-PTV方法的MLD截断值为12.5 Gy。
- 为使RP2发生率低于20%,Lung-PGTV方法的MLD截断值为14.2 Gy。
- 为使RP2发生率低于20%,全肺方法的MLD截断值为15.0 Gy。
- Lung-PTV方法所得MLD预测RP2的AUC=0.647,Lung-PGTV方法所得MLD的AUC=0.609(P=0.006)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung dose-volume histogram (DVH) in radiotherapy could be calculated from multiple normal lung definitions. The lung dosimetric parameters generated from various approaches are significantly different. However, limited evidence shows which definition should be used to more accurately predict radiation pneumonitis (RP). We aimed to compare the RP prediction accuracy of dosimetric parameters from three lung volume methods in lung cancer patients treated with Intensity-Modulated Radiation Therapy (IMRT). METHODS: We retrospectively reviewed 183 consecutive lung cancer patients treated with IMRT from January 2014 to October 2017. The normal lungs were defined by total bilateral lung volume (Total Lung), excluding PTV (Lung-PTV) or PGTV (Lung-PGTV). V5, V20, and mean lung dose (MLD) have been extracted from three definitions. The primary endpoint was acute grade 2 or higher RP (RP2). Correlation between RP2 and dose parameters were analyzed by logistic regression. We evaluated prediction performance using area under the receiver operating characteristic curve (AUC) and normal tissue complication probability (NTCP) model. RESULTS: Twenty-six patients (14.2%) developed acute RP2 after IMRT treatment. Significant dosimetric differences were found between any 2-paired lung volumes (Ps < 0.001). To limit RP2 incidence less than 20%, the cutoff MLDs were 12.5 Gy, 14.2 Gy, and 15.0 Gy, respectively, for Lung-PTV, Lung-PGTV, and Total Lung methods. There were 54% (13% vs. 20%) and 45% (20% vs. 29%) RP2 probability variances detected at each MLD cutoff points from Lung-PTV and Lung-PGTV definitions. The best RP prediction performance was found in MLD from Lung-PTV method (AUC = 0.647), which is significantly better (P = 0.006) than the MLD from Lung-PGTV method (AUC = 0.609). CONCLUSION: There are significant differences in acute RP2 rate prediction using dosimetric parameters from various normal lung definitions. Excluding PTV from total lung volume may be more accurate and promising to predict acute symptomatic radiation pneumonitis in IMRT treated lung cancer patients.
引用
- Meng Y, Yang H, Wang W, et al. Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients. Radiat Oncol. 2019. PMID: 30642354. doi:10.1186/s13014-018-1204-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。